Back to News
Reassurance about the use of Oxford Astra Zeneca vaccine
Posted on 23 Mar 2021
· We are aware that there have been reports about the Oxford AstraZeneca COVID-19 vaccine, however the UK regulators are clear that the vaccine should continue to be used and people should attend their appointments.
· The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines and is responsible for the regulation of the vaccines being offered as part of this programme and they have reviewed all of the evidence.
· Their statement says that the available evidence does not suggest that blood clots in veins (venous thromboembolism) are caused by COVID-19 Vaccine AstraZeneca and people should go to their appointments as this is vital protection from COVID-19.
· This follows a detailed review of reported cases as well as data from hospital admissions and GP records.
· There is no evidence that blood clots in the veins are occurring more often in people who have received the vaccine than in people who have not, for either vaccine.
· The MHRA’s advice remains that the benefits of the vaccine against COVID-19, with its associated risk of hospitalisation and death, continue to outweigh the risks of potential side effects.
· People should go and get their COVID-19 vaccine when invited to do so.